Role of Laboratory-Based Risk Stratification Models in Predicting Disease Severity
ICME JOURNAL OF LABORATORY MEDICINE · 2026 · 5-6
DOI: 10.54646/icme.2026.3 ↗Kurz gefasst
Fachartikel in der Zeitschrift ICME JOURNAL OF LABORATORY MEDICINE, 2026. Verfasst von Riju Mathew.
Abstract (Originalsprache)
Risk stratification plays a critical role in modern clinical decision-making by enabling early identification of patients at risk of developing severe disease outcomes. Laboratory-based risk stratification models utilize routinely available biochemical and hematological parameters to predict disease severity, progression, and mortality. These models offer a cost-effective, objective, and scalable approach for supporting clinicians in triage, treatment prioritization, and resource allocation. This paper reviews the role of laboratory-based risk stratification models in predicting disease severity across various clinical conditions. It examines commonly used biomarkers, model development approaches, clinical applications, advantages, and limitations. The study highlights the growing importance of integrating laboratory data with predictive analytics to improve patient outcomes and emphasizes future directions for enhancing model accuracy through artificial intelligence and machine learning techniques.
Zitieren
APA
Mathew, R. (2026). Role of Laboratory-Based Risk Stratification Models in Predicting Disease Severity. ICME JOURNAL OF LABORATORY MEDICINE, 5-6. https://doi.org/10.54646/icme.2026.3
Vancouver
Mathew R. Role of Laboratory-Based Risk Stratification Models in Predicting Disease Severity. ICME JOURNAL OF LABORATORY MEDICINE. 2026:5-6. doi:10.54646/icme.2026.3
BibTeX
@article{Mathew2026,
author = {Mathew, Riju},
title = {Role of Laboratory-Based Risk Stratification Models in Predicting Disease Severity},
journal = {ICME JOURNAL OF LABORATORY MEDICINE},
year = {2026},
pages = {5--6},
doi = {10.54646/icme.2026.3}
}
EUVIMED